Kalexo Bio: A New Era in siRNA Therapy for Cardiovascular Health Mabwell and Aditum Bio have joined forces to create Kalexo Bio, aiming to advance siRNA therapy for cardiovascular disorders through innovative research.

Kalexo Bio: A New Era in siRNA Therapy for Cardiovascular Health #None #siRNA_therapy #Aditum_Bio #Mabwell_Biotech

Mabwell Bioscience Partners with Aditum Bio to Launch Kalexo Bio for siRNA Cardiovascular Therapy Mabwell and Aditum Bio have founded Kalexo Bio to develop innovative siRNA therapies targeting cardiovascular disorders, promising new hope for patients.

Mabwell Bioscience Partners with Aditum Bio to Launch Kalexo Bio for siRNA Cardiovascular Therapy #China #Shanghai #Mabwell_Bioscience #Aditum_Bio #Kalexo_Bio